Pharmaceutical safety is an essential factor in the development of every medicament. It is essential to establish that an investigational product has antiviral activity at concentrations that can be achieved in vivo without inducing toxic effects to cells. Furthermore, in a cell culture model, the apparent antiviral activity of an investigational product can be the result of host cell death after exposure to the product. Thus, it is crucial to determine the cytotoxic potential of the formulation on the cell line used in the antiviral assays. https://antiviral.creative-dia....gnostics.com/cc50-ic

Favicon 
antiviral.creative-diagnostics.com

CC<sub>50</sub>/ IC<sub>50</sub> Assay - Creative Diagnostics

We combine infection and analytical expertise to provide our clients with CC50/ IC50 Assay to reveal the action mechanism of new antiviral drugs.